Concepedia
Statistics
Publications
4
Citations
107
H-Index
Active since
1999
Affiliations
Kindai University(Current)
The University of Texas MD Anderson Cancer Center
Université Toulouse III - Paul Sabatier
Seoul National University Hospital
Seoul National University
H. Hayashi is an author at Kindai University specializing in oncogenes, tyrosine kinase inhibitors, and medicine.
Publications per year
1999–2024
Multimodal analysis of prompt neutron spectra for 237Np(n,f)
Takaaki Ohsawa, Tetsuo Horiguchi, H. Hayashi · Nuclear Physics A · 1999 · 42 citations
Natural Sciences, Nuclear Engineering, Physics +14
LBA52 Tepotinib + osimertinib for EGFRm NSCLC with MET amplification (METamp) after progression on first-line (1L) osimertinib: Initial results from the INSIGHT 2 study
Julien Mazières, T.M. Kim, Boon Khaw Lim et al. · Annals of Oncology · 2022 · 40 citations
Medicine, Oncology, Pharmacology +10
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
X. Le, Y. Zhao, D. Planchard et al. · Journal of Thoracic Oncology · 2024 · 13 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +5
OA21.05 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis
T.M. Kim, Valentina Guarneri, V. Pei Jye et al. · Journal of Thoracic Oncology · 2023 · 12 citations · Full text
Medicine, Molecular Biology, Molecular Oncology +16
1–4 of 4